678 related articles for article (PubMed ID: 10336191)
1. Parathyroid imaging with Tc-99m sestamibi planar and SPECT scintigraphy.
Nguyen BD
Radiographics; 1999; 19(3):601-14; discussion 615-6. PubMed ID: 10336191
[TBL] [Abstract][Full Text] [Related]
2. Double-phase Tc-99m sestamibi scintigraphy in the preoperative location of lesions causing hyperparathyroidism.
Blanco I; Carril JM; Banzo I; Quirce R; Gutierrez C; Uriarte I; Montero A; Vallina NK
Clin Nucl Med; 1998 May; 23(5):291-7. PubMed ID: 9596153
[TBL] [Abstract][Full Text] [Related]
3. Radionuclide imaging of the parathyroid glands: patterns, pearls, and pitfalls.
Smith JR; Oates ME
Radiographics; 2004; 24(4):1101-15. PubMed ID: 15256632
[TBL] [Abstract][Full Text] [Related]
4. Limited sensitivity of parathyroid imaging with (99m)Tc-sestamibi/(123)I subtraction in an endemic goiter area.
Rink T; Schroth HJ; Holle LH; Garth H
J Nucl Med; 2002 Sep; 43(9):1175-80. PubMed ID: 12215555
[TBL] [Abstract][Full Text] [Related]
5. Technetium-99m-sestamibi single agent localization versus high resolution ultrasonography for the preoperative localization of parathyroid glands in patients with primary hyperparathyroidism.
Billy HT; Rimkus DR; Hartzman S; Latimer RG
Am Surg; 1995 Oct; 61(10):882-8. PubMed ID: 7668462
[TBL] [Abstract][Full Text] [Related]
6. Prospective comparison of technetium-99m-sestamibi/iodine-123 radionuclide scan versus high-resolution ultrasonography for the preoperative localization of abnormal parathyroid glands in patients with previously unoperated primary hyperparathyroidism.
Casas AT; Burke GJ; Sathyanarayana ; Mansberger AR; Wei JP
Am J Surg; 1993 Oct; 166(4):369-73. PubMed ID: 8214295
[TBL] [Abstract][Full Text] [Related]
7. Parathyroid imaging with pertechnetate plus perchlorate/MIBI subtraction scintigraphy: a fast and effective technique.
Rubello D; Saladini G; Casara D; Borsato N; Toniato A; Piotto A; Bernante P; Pelizzo MR
Clin Nucl Med; 2000 Jul; 25(7):527-31. PubMed ID: 10885694
[TBL] [Abstract][Full Text] [Related]
8. Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Lind P
Invest Radiol; 2000 Aug; 35(8):453-9. PubMed ID: 10946972
[TBL] [Abstract][Full Text] [Related]
9. Localization of an ectopic parathyroid adenoma by double-phase technetium-99m-sestamibi scintigraphy.
Caravalho J; Balingit AG; Rivera-Rodríguez JE; Shriver CD; Koops MK
J Nucl Med; 1995 Oct; 36(10):1840-2. PubMed ID: 7562052
[TBL] [Abstract][Full Text] [Related]
10. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
[TBL] [Abstract][Full Text] [Related]
11. Preoperative technetium Tc 99m sestamibi SPECT imaging in the management of primary hyperparathyroidism in patients with concomitant multinodular goiter.
Lorberboym M; Ezri T; Schachter PP
Arch Surg; 2005 Jul; 140(7):656-60. PubMed ID: 16027330
[TBL] [Abstract][Full Text] [Related]
12. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
[TBL] [Abstract][Full Text] [Related]
13. Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with (99m)technetium sestamibi scintigraphy.
Haber RS; Kim CK; Inabnet WB
Clin Endocrinol (Oxf); 2002 Aug; 57(2):241-9. PubMed ID: 12153604
[TBL] [Abstract][Full Text] [Related]
14. Preoperative evaluation of parathyroid lesions in patients with concomitant thyroid disease: role of high resolution ultrasonography and dual phase technetium 99m sestamibi scintigraphy.
Kebapci M; Entok E; Kebapci N; Adapinar B
J Endocrinol Invest; 2004 Jan; 27(1):24-30. PubMed ID: 15053239
[TBL] [Abstract][Full Text] [Related]
15. Preliminary experience with double-phase SPECT using Tc-99m sestamibi in patients with hyperparathyroidism.
Neumann DR; Esselstyn CB; Kim EY; Go RT; Obuchowski NA; Rice TW
Clin Nucl Med; 1997 Apr; 22(4):217-21. PubMed ID: 9099475
[TBL] [Abstract][Full Text] [Related]
16. Preoperative parathyroid scintigraphic lesion localization: accuracy of various types of readings.
Nichols KJ; Tomas MB; Tronco GG; Rini JN; Kunjummen BD; Heller KS; Sznyter LA; Palestro CJ
Radiology; 2008 Jul; 248(1):221-32. PubMed ID: 18483228
[TBL] [Abstract][Full Text] [Related]
17. Impact of technetium-99m-sestamibi localization on operative time and success of operations for primary hyperparathyroidism.
Casas AT; Burke GJ; Mansberger AR; Wei JP
Am Surg; 1994 Jan; 60(1):12-6; discussion 16-7. PubMed ID: 8273968
[TBL] [Abstract][Full Text] [Related]
18. [99m Tc-sestamibi in the diagnosis of the location of hyperparathyroidism].
Berná Roqueta L
Rev Esp Med Nucl; 1998; 17(2):102-11. PubMed ID: 9611280
[No Abstract] [Full Text] [Related]
19. [Tc-99-sestamibi scan in the preoperative localization of abnormal hyperfunctioning parathyroid glands].
Bruno OD; Degrossi OJ; Curutchet HP; Castellanos AA; Alak MC; Arébalo-Cross G; Montesinos M; García AJ; García del Río H; Mezzadri NA
Medicina (B Aires); 1996; 56(5 Pt 1):441-7. PubMed ID: 9239878
[TBL] [Abstract][Full Text] [Related]
20. The usefulness of Tc-99m tetrofosmin scintigraphy in the diagnosis and localization of hyperfunctioning parathyroid glands.
Vallejos V; Martin-Comin J; Gonzalez MT; Rafecas R; Muñoz A; Fernãndez A; Mora J; Ramos M
Clin Nucl Med; 1999 Dec; 24(12):959-64. PubMed ID: 10595477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
